Piflufolastat

• CAS: 1423758-00-2
• Catalog Number: ACM1423758002
• Category: Others
• Molecular Weight: 442.40
• Molecular Formula: C18H23FN4O8
• Description: Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate cancer. Piflufolastat F-18 is a radioactive diagnostic agent used for positron emission tomography (PET) imaging. It was approved in 2021. Piflufolastat we are supplying is not radio-label compound.
• Synonyms: DCFPYL; Piflufolastat
• IUPAC Name: (((S)-1-carboxy-5-(6-fluoronicotinamido)pentyl)carbamoyl)-L-glutamic acid
• Canonical SMILES: O=C(O)CC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCCCNC(C1=CC=C(F)N=C1)=O)=O
• InChI: InChI=1S/C18H23FN4O8/c19-13-6-4-10(9-21-13)15(26)20-8-2-1-3-11(16(27)28)22-18(31)23-12(17(29)30)5-7-14(24)25/h4,6,9,11-12H,1-3,5,7-8H2,(H,20,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/t11-,12-/m0/s1
• InChI Key: OLWVRJUNLXQDSP-RYUDHWBXSA-N
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Shelf Life: >3 years if stored properly
• Storage: Dry, dark and at 0-4 °C for short term (days to weeks) or -20 °C for long term (months to years).
• Alternative CAS: 1207181-29-0 (F18); 1423758-00-2 (F-19)
• Biological Target: Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate cancer.
• Drug Formulation: This drug may be formulated in DMSO
• Elemental Analysis: C, 48.87; H, 5.24; F, 4.29; N, 12.66; O, 28.93
• Exact Mass: 442.15
• HS Tariff Code: 2934.99.03.00
• In Vitro Activity: TBD
• In Vivo Activity: TBD
• Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
• Stock Solution Storage: 0-4 °C for short term (days to weeks), or -20 °C for long term (months).